Search Results - "Deierhoi, M"

Refine Results
  1. 1

    Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients by Allon, Michael, Lockhart, Mark E., Lilly, Regina Z., Gallichio, Michael H., Young, Carlton J., Barker, Jill, Deierhoi, Mark H., Robbin, Michelle L.

    Published in Kidney international (01-11-2001)
    “…Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients. Current DOQI guidelines encourage placing arteriovenous (AV)…”
    Get full text
    Journal Article
  2. 2

    A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation by PIRSCH, J. D, MILLER, J, DEIERHOI, M. H, VINCENTI, F, FILO, R. S

    Published in Transplantation (15-04-1997)
    “…Tacrolimus (FK506), a macrolide molecule that potently inhibits the expression of interleukin 2 by T lymphocytes, represents a potential major advance in the…”
    Get full text
    Journal Article
  3. 3

    Predictors of adequacy of arteriovenous fistulas in hemodialysis patients by Miller, Paul E., Tolwani, Ashita, Luscy, C. Peter, Deierhoi, Mark H., Bailey, Robert, Redden, David T., Allon, Michael

    Published in Kidney international (01-07-1999)
    “…Predictors of adequacy of arteriovenous fistulas in hemodialysis patients. Dialysis access procedures and complications represent a major cause of morbidity,…”
    Get full text
    Journal Article
  4. 4

    US vascular mapping before hemodialysis access placement by Robbin, M L, Gallichio, M H, Deierhoi, M H, Young, C J, Weber, T M, Allon, M

    Published in Radiology (01-10-2000)
    “…To prospectively assess the effect of preoperative ultrasonographic (US) mapping on surgical selection, placement of arteriovenous fistulas (AVFs) and grafts,…”
    Get more information
    Journal Article
  5. 5

    Natural history of arteriovenous grafts in hemodialysis patients by Miller, Paul E., Carlton, Donna, Deierhoi, Mark H., Redden, David T., Allon, Michael

    Published in American journal of kidney diseases (01-07-2000)
    “…Most hemodialysis patients in the United States have an arteriovenous graft as their vascular access. Grafts have a relatively short life span and are prone to…”
    Get full text
    Journal Article
  6. 6

    Secondary Listing for Deceased‐Donor Kidney Transplantation Does Not Increase Likelihood of Engraftment at a Large Transplant Center by Kumar, V., Julian, B. A., Deierhoi, M. H., Curtis, J. J.

    Published in American journal of transplantation (01-07-2009)
    “…The supply of donor organs has not increased as fast as has the number of patients awaiting kidney transplantation. Few organs are shared outside the areas of…”
    Get full text
    Journal Article
  7. 7

    A multidisciplinary approach to hemodialysis access: Prospective evaluation by Allon, Michael, Bailey, Robert, Ballard, Robert, Deierhoi, Mark H., Hamrick, Kay, Oser, Rachel, Rhynes, V. Keith, Robbin, Michelle L., Saddekni, Souheil, Zeigler, Stephen T.

    Published in Kidney international (01-02-1998)
    “…A multidisciplinary approach to hemodialysis access: Prospective evaluation. Dialysis access procedures and complications represent a major cause of morbidity,…”
    Get full text
    Journal Article
  8. 8

    Mycophenolate mofetil in cadaveric renal transplantation

    Published in American journal of kidney diseases (01-08-1999)
    “…This report extends the randomized, double-blind, multicenter trial at 14 centers in the United States that compared triple-therapy regimens containing…”
    Get full text
    Journal Article
  9. 9

    RS-61443--a phase I clinical trial and pilot rescue study by Sollinger, H W, Deierhoi, M H, Belzer, F O, Diethelm, A G, Kauffman, R S

    Published in Transplantation (01-02-1992)
    “…RS-61443, a morpholinoethyl ester of mycophenolic acid, inhibits the synthesis of guanosine monophosphate, which plays a pivotal role in lymphocyte metabolism…”
    Get more information
    Journal Article
  10. 10

    Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients by Barber, W H, Mankin, J A, Laskow, D A, Deierhoi, M H, Julian, B A, Curtis, J J, Diethelm, A G

    Published in Transplantation (01-01-1991)
    “…Experimental studies have shown that antilymphocyte globulin combined with transfusion of donor-specific bone marrow cells can induce partial tolerance to…”
    Get more information
    Journal Article
  11. 11

    The number of amino acid residues mismatches correlates with flow cytometry crossmatching results in high PRA renal patients by Lobashevsky, A.L, Senkbeil, R.W, Shoaf, J.L, Stephenson, A.K, Skelton, S.B, Burke, R.M, Deierhoi, M.H, Thomas, J.M

    Published in Human immunology (01-05-2002)
    “…Highly sensitized renal transplant candidates present a group at high risk for acute and chronic rejection. The probability of finding compatible donors for…”
    Get full text
    Journal Article
  12. 12

    Mycophenolate mofetil for the treatment of a first acute renal allograft rejection by Pescovitz, MD

    Published in Transplantation (27-01-1998)
    “…Mycophenolate mofetil (MMF) significantly reduces the incidence of acute allograft rejection in renal transplant patients. The effect of adding MMF to the…”
    Get full text
    Conference Proceeding Journal Article
  13. 13

    Risk factors affecting second renal transplant outcome, with special reference to primary allograft nephrectomy by Abouljoud, M S, Deierhoi, M H, Hudson, S L, Diethelm, A G

    Published in Transplantation (27-07-1995)
    “…Removal of a failed primary renal allograft was found by some groups to adversely affect the outcome of a second kidney transplant. Recent data does not…”
    Get more information
    Journal Article
  14. 14

    Impact of donor/recipient size matching on outcomes in renal transplantation by GASTON, R. S, HUDSON, S. L, JULIAN, B. A, LASKOW, D. A, DEIERHOI, M. H, SANDERS, C. E, PHILLIPS, M. G, DIETHELM, A. G, CURTIS, J. J

    Published in Transplantation (15-02-1996)
    “…Interest in nonimmunologic factors affecting longterm graft survival has focused on adequacy of nephron dosing. Body surface are (BSA) is a reliable surrogate…”
    Get full text
    Conference Proceeding Journal Article
  15. 15

    Treatment of recurrent heart rejection with mycophenolate mofetil (RS-61443): initial clinical experience by Kirklin, J K, Bourge, R C, Naftel, D C, Morrow, W R, Deierhoi, M H, Kauffman, R S, White-Williams, C, Nomberg, R I, Holman, W L, Smith, Jr, D C

    “…Mycophenolate mofetil (RS-61443), a derivative of mycophenolic acid, is a new immunosuppressive agent that inhibits de novo purine synthesis in activated…”
    Get more information
    Journal Article
  16. 16
  17. 17

    OKT3 first-dose reaction: Association with T cell subsets and cytokine release by Gaston, Robert S., Deierhoi, Mark H., Patterson, Trudie, Prasthofer, Edward, Julian, Bruce A., Barber, W. Henry, Laskow, David A., Diethelm, Arnold G., Curtis, John J.

    Published in Kidney international (01-01-1991)
    “…OKT3 first-dose reaction: Association with T cell subsets and cytokine release. Use of the monoclonal antibody OKT3 to prevent or treat allograft rejection has…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Tolerance in renal transplantation after allogeneic bone marrow transplantation-6-year follow-up by SELLERS, Marty T, DEIERHOI, Mark H, CURTIS, John J, GASTON, Robert S, JULIAN, Bruce A, LANIER, Douglas C, DIETHELM, Arnold G

    Published in Transplantation (15-06-2001)
    “…Despite significant advancements in clinical transplantation, very few reports describe the long-term acceptance of transplanted solid organs without…”
    Get full text
    Journal Article
  20. 20

    Improved survival of primary cadaveric renal allografts in blacks with quadruple immunosuppression by Gaston, R S, Hudson, S L, Deierhoi, M H, Barber, W H, Laskow, D A, Julian, B A, Curtis, J J, Barger, B O, Shroyer, T W, Diethelm, A G

    Published in Transplantation (01-01-1992)
    “…Black recipients of cadaveric kidneys have been shown to have a lower rate of allograft survival than whites. Data were reviewed from 642 primary cadaveric…”
    Get more information
    Journal Article